Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Teva rejected opportunity to acquire Perrigo

Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo’s main activity.

(L_R) Teva CEO EREZ VIGODMAN and PERRIGO CEO Joseph Papa

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, sources inform “Globes.” Perrigo hired bankers last summer to assess the possibility of its sale via a merger with a large pharmaceuticals company, and those bankers approached Teva and proposed that it acquire Perrigo….  [READ MORE]

Published by Globes [online], Israel business news – www.globes-online.com

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

***

READ MORE:

 

 

Newsletter



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

History & Archeology

A groundbreaking discovery in the Manot Cave in the Western Galilee, Israel has unearthed the earliest evidence in the Levant (and among the world's...